Mitchell Hull

5.4k total citations · 2 hit papers
26 papers, 3.2k citations indexed

About

Mitchell Hull is a scholar working on Molecular Biology, Infectious Diseases and Cell Biology. According to data from OpenAlex, Mitchell Hull has authored 26 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Infectious Diseases and 5 papers in Cell Biology. Recurrent topics in Mitchell Hull's work include Ubiquitin and proteasome pathways (4 papers), Protein Degradation and Inhibitors (4 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Mitchell Hull is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Protein Degradation and Inhibitors (4 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Mitchell Hull collaborates with scholars based in United States, France and United Kingdom. Mitchell Hull's co-authors include R. Marc Learned, Makoto Makishima, Kevin D. Lustig, Bei Shan, David J. Mangelsdorf, Joyce J. Repa, Hua Tu, Peter Coward, Jürgen M. Lehmann and Emily Chen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Mitchell Hull

25 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Nuclear Receptor for Bile Acids

1999 2.2k citations Makoto Makishima, Joyce J. Repa et al. Science profile →
Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry

2020 152 citations Seiya Kitamura, Qinheng Zheng et al. Journal of the American Chemical Society profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitchell Hull United States	14	1.6k	1.3k	1.0k	637	427	26	3.2k
Claudio D’Amore Italy	29	854 0.5×	918 0.7×	482 0.5×	455 0.7×	307 0.7×	72	2.4k
María J. Monte Spain	36	2.1k 1.3×	1.1k 0.9×	1.2k 1.1×	814 1.3×	167 0.4×	115	3.8k
Gyan Chandra United States	8	1.8k 1.1×	898 0.7×	1.1k 1.0×	594 0.9×	340 0.8×	8	2.6k
Maria Chiara Monti Italy	32	702 0.4×	1.1k 0.9×	413 0.4×	444 0.7×	253 0.6×	134	2.7k
María A. Serrano Spain	33	1.6k 1.0×	825 0.7×	797 0.8×	427 0.7×	87 0.2×	103	3.1k
Rocı́o I.R. Macı́as Spain	39	2.4k 1.5×	1.3k 1.0×	1.4k 1.3×	581 0.9×	82 0.2×	143	4.3k
Genta Kakiyama United States	26	640 0.4×	1.3k 1.0×	607 0.6×	969 1.5×	89 0.2×	64	2.4k
Nicholas Murgolo United States	30	787 0.5×	1.8k 1.4×	1.5k 1.4×	476 0.7×	299 0.7×	64	4.3k
Valentina Sepe Italy	26	713 0.4×	638 0.5×	367 0.4×	318 0.5×	178 0.4×	72	1.9k
Péter Krajcsi Hungary	32	1.7k 1.0×	1.3k 1.0×	283 0.3×	246 0.4×	695 1.6×	92	3.2k

Countries citing papers authored by Mitchell Hull

Since Specialization

Citations

This map shows the geographic impact of Mitchell Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Hull more than expected).

Fields of papers citing papers by Mitchell Hull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Hull. The network helps show where Mitchell Hull may publish in the future.

Co-authorship network of co-authors of Mitchell Hull

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Hull. A scholar is included among the top collaborators of Mitchell Hull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Hull. Mitchell Hull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Emery, Meredith E. Davis-Gardner, Rubén D. Garcia-Ordoñez, et al.. (2023). High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2. SLAS DISCOVERY. 28(3). 95–101. 13 indexed citations

Tärning, Joel, Aurélie Fricot, Pablo Gamallo, et al.. (2023). Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening. Nature Communications. 14(1). 1951–1951. 7 indexed citations

Chen, Emily, et al.. (2023). A covalent inhibitor of the YAP–TEAD transcriptional complex identified by high-throughput screening. RSC Chemical Biology. 4(11). 894–905. 3 indexed citations

Grzelak, Edyta M., et al.. (2023). Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2. eLife. 12. 1 indexed citations

Tran, Tuan Anh, Siying Zhu, Seung‐Hyuk Choi, et al.. (2021). A small molecule UPR modulator for diabetes identified by high throughput screening. Acta Pharmaceutica Sinica B. 11(12). 3983–3993. 11 indexed citations

Kitamura, Seiya, Natalia Milosevich, Joshua N. Asiaban, et al.. (2021). Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia. ACS Central Science. 7(5). 815–830. 63 indexed citations

Shalhout, Sophia Z., Pengyu Yang, Edyta M. Grzelak, et al.. (2021). YAP-dependent proliferation by a small molecule targeting annexin A2. Nature Chemical Biology. 17(7). 767–775. 44 indexed citations

Kitamura, Seiya, Qinheng Zheng, Jordan L. Woehl, et al.. (2020). Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry. Journal of the American Chemical Society. 142(25). 10899–10904. 152 indexed citations breakdown →

Rice, Christopher A., Beatrice L. Colon, Emily Chen, Mitchell Hull, & Dennis E. Kyle. (2020). Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae. PLoS neglected tropical diseases. 14(9). e0008353–e0008353. 45 indexed citations

10.

Smith, Emery, Meredith E. Davis-Gardner, Rubén D. Garcia-Ordoñez, et al.. (2020). High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2. SLAS DISCOVERY. 25(10). 1152–1161. 38 indexed citations

11.

Wall, Gina, Emily Chen, Mitchell Hull, & José L. López-Ribot. (2020). Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation. Frontiers in Cellular and Infection Microbiology. 10. 597931–597931. 11 indexed citations

12.

Kim, Yu-Jin, Beatrice Cubitt, Emily Chen, et al.. (2019). The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors. Antiviral Research. 169. 104558–104558. 25 indexed citations

13.

Xu, Zhengren, Shiming Fang, Malina A. Bakowski, et al.. (2019). Discovery of Kirromycins with Anti-Wolbachia Activity from Streptomyces sp. CB00686. ACS Chemical Biology. 14(6). 1174–1182. 6 indexed citations

14.

Janes, Jeff, Emily Chen, Nicole H. Rogers, et al.. (2018). The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. Proceedings of the National Academy of Sciences. 115(42). 10750–10755. 125 indexed citations

15.

Choi, Seung Hyuk, Sang Jun Lee, Mitchell Hull, et al.. (2017). Targeted Disruption of Myc–Max Oncoprotein Complex by a Small Molecule. ACS Chemical Biology. 12(11). 2715–2719. 52 indexed citations

16.

Lee, Sang Jun, Huafei Zou, Elizabeth Chao, et al.. (2017). A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening. Scientific Reports. 7(1). 5824–5824. 12 indexed citations

17.

Mietton, Flore, Elena Ferri, Danièle Maubon, et al.. (2017). Selective BET bromodomain inhibition as an antifungal therapeutic strategy. Nature Communications. 8(1). 15482–15482. 35 indexed citations

18.

Liu, Tao, Yi Yan, Ying Wang, et al.. (2014). Rational Design of CXCR4 Specific Antibodies with Elongated CDRs. Journal of the American Chemical Society. 136(30). 10557–10560. 31 indexed citations

19.

Rines, Daniel R., Buu P. Tu, Loren Miraglia, et al.. (2006). High‐Content Screening of Functional Genomic Libraries. Methods in enzymology on CD-ROM/Methods in enzymology. 414. 530–565. 16 indexed citations

20.

Makishima, Makoto, Joyce J. Repa, Hua Tu, et al.. (1999). Identification of a Nuclear Receptor for Bile Acids. Science. 284(5418). 1362–1365. 2206 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact